ECT denied as experimental or investigational by Cigna?

Cigna's specific coverage criteria for ect are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Deny Electroconvulsive Therapy (ECT) as Experimental or Investigational

Electroconvulsive therapy has been used in clinical psychiatry for decades and carries FDA clearance for its delivery devices. An "experimental or investigational" denial from Cigna is almost always a misapplication of its coverage criteria — either because a reviewer conflated ECT with a newer or modified form of the procedure, applied outdated policy language, or incorrectly coded the claim. Occasionally, the denial arises when ECT is requested for an indication that Cigna's current policy does not list as an established use, even when professional medical societies recognize that indication.

## Why This Denial Is Appealable

Cigna's own medical coverage policies for ECT typically acknowledge it as an established, non-experimental procedure for certain psychiatric conditions. An experimental denial that contradicts the plan's own published coverage policy is facially defective and should be overturned on internal appeal. Under ERISA §503 and ACA §2719, the plan must conduct a full-and-fair individualized review — not a categorical exclusion. The Mental Health Parity and Addiction Equity Act further prohibits applying coverage-restriction standards to mental health procedures that would not be applied to analogous medical or surgical procedures.

## Federal Appeal Framework

• Internal appeal: File within the deadline on your denial notice. Specifically request the clinical rationale and any evidence review Cigna used to classify ECT as experimental for your indication.
• External review: Available after final internal denial. An independent IRO experienced in psychiatric coverage is particularly valuable for experimental-treatment denials because the IRO will apply recognized clinical standards — not the insurer's proprietary criteria. The standard external-review window is approximately four months from the final adverse determination; expedited review is available when clinically urgent.

## Concrete Appeal Steps

1. Obtain Cigna's published medical coverage policy for ECT and compare it to the denial letter — if the policy acknowledges ECT as established, cite that directly. 2. Have your treating psychiatrist write a letter confirming that the specific procedure and indication are consistent with established psychiatric practice and recognized clinical guidelines. 3. Request that Cigna identify the specific evidence standard it applied to reach the experimental conclusion and provide the underlying evidence review. 4. Raise MHPAEA if Cigna would not classify an analogous medical procedure as experimental under the same evidentiary standard. 5. Submit the internal appeal; if denied, escalate immediately to external review given the well-established clinical status of ECT.

## Documentation to Gather

• Diagnosis confirmation: Current psychiatric evaluation establishing the diagnosis, severity, and duration of the condition.
• Prior-treatment history: Complete dated records of all prior treatments, responses, and failures — demonstrating that the condition meets criteria for a level of severity at which ECT is a recognized intervention.
• Clinical severity: Psychiatrist's assessment of current functional status, safety risks, and the clinical urgency of ECT access.
• Prescriber medical-necessity letter: A letter from the treating psychiatrist specifically rebutting the experimental characterization and citing the applicable guideline organization (such as the American Psychiatric Association) that recognizes ECT as an established treatment for this indication.
• Cigna's own policy: A printout of Cigna's current ECT medical coverage policy, with relevant passages highlighted, demonstrating internal inconsistency in the denial.

## Criteria-Mapping Structure

Obtain Cigna's ECT coverage criteria. For each listed established indication or requirement, map it to the specific chart documentation showing your case qualifies. If Cigna's policy acknowledges ECT as established, include that policy text alongside the denial letter in your appeal — the contradiction between them is often sufficient to compel overturn at internal review.